Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
Make a selection below to explore our full database of 16 results matching: "Low-Molecular-Weight Heparin"
ACE Reports
(16 Reports)
ACE Reports
Originals
(0 Articles)
Originals
Podcasts
(0 Videos)
Podcasts
Our AI driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Trauma
OTA 2022: Aspirin vs Low-Molecular-Weight Heparin for Thromboprophylaxis
OTA 2022: Aspirin vs Low-Molecular-Weight Heparin for Thromboprophylaxis
Peri-Operative
Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis.
Blood Coagul Fibrinolysis. 2024 01-Jun;():. 10.1097/MBC.0000000000001300
Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis.
Blood Coagul Fibrinolysis. 2024 01-Jun;():. 10.1097/MBC.0000000000001300
Peri-Operative
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials.
J Orthop Surg Res. 2024 01-Sep;():. 10.1186/s13018-024-05087-y
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials.
J Orthop Surg Res. 2024 01-Sep;():. 10.1186/s13018-024-05087-y
Arthroplasty
A Comparison Between Fondaparinux Sodium and Low-Molecular-Weight Heparin in Preventing Patients Undergoing Hip Replacement from Deep Vein Thrombosis.
J Musculoskelet Neuronal Interact. 2024 01-Jun;():.
A Comparison Between Fondaparinux Sodium and Low-Molecular-Weight Heparin in Preventing Patients Undergoing Hip Replacement from Deep Vein Thrombosis.
J Musculoskelet Neuronal Interact. 2024 01-Jun;():.
Arthroplasty
The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials.
Int J Surg. 2023 01-Nov;():. 10.1097/JS9.0000000000000656
The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials.
Int J Surg. 2023 01-Nov;():. 10.1097/JS9.0000000000000656
Trauma
Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture
N Engl J Med. 2022 01-Dec;():. 10.1056/NEJMoa2205973
Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture
N Engl J Med. 2022 01-Dec;():. 10.1056/NEJMoa2205973
General Orthopaedics
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
PloS one. 2020 Aug-03;():. 10.1371/journal.pone.0235628
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
PloS one. 2020 Aug-03;():. 10.1371/journal.pone.0235628
Trauma
A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Trial Comparing Bleeding Events after Orthopaedic Trauma with Aspirin to Low Molecular Weight Heparin Prophylaxis
A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Trial Comparing Bleeding Events after Orthopaedic Trauma with Aspirin to Low Molecular Weight Heparin Prophylaxis
Trauma
A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Bleeding Events After Orthopaedic Trauma With Aspirin to Low Molecular Weight Heparin Venous Thromboembolism Prophylaxis
A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Bleeding Events After Orthopaedic Trauma With Aspirin to Low Molecular Weight Heparin Venous Thromboembolism Prophylaxis
General Orthopaedics
Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis
PLoS One. 2018 Jun 21;13(6):e0197868
Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis
PLoS One. 2018 Jun 21;13(6):e0197868
General Orthopaedics
Inpatient Compliance with Venous Thromboembolism Prophylaxis in Orthopaedic Trauma: A Pragmatic Randomized Controlled Trial of Aspirin Versus Low Molecular Weight Heparin
Inpatient Compliance with Venous Thromboembolism Prophylaxis in Orthopaedic Trauma: A Pragmatic Randomized Controlled Trial of Aspirin Versus Low Molecular Weight Heparin
Trauma
Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials
Arthroscopy. 2014 Aug;30(8):987-96
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials
This report has been verified by one or more authors of the original publication.
Arthroscopy. 2014 Aug;30(8):987-96
Arthroplasty
Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin
J Bone Joint Surg Am. 2010 Mar;92(3):527-35
Includes Author Interview
Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin
This report has been verified by one or more authors of the original publication.
J Bone Joint Surg Am. 2010 Mar;92(3):527-35
Arthroplasty
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial
Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial
This report has been verified by one or more authors of the original publication.
Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004
General Orthopaedics
Extended Venous Thromboembolism (VTE) Prophylaxis after Hip Fracture Surgery with the Ultra-Low-Molecular-Weight Heparin(ULMWH) Semuloparin
Extended Venous Thromboembolism (VTE) Prophylaxis after Hip Fracture Surgery with the Ultra-Low-Molecular-Weight Heparin(ULMWH) Semuloparin
Arthroplasty
Portable Compression Device and Low-Molecular-Weight Heparin Compared With Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Joint Arthroplasty
J Arthroplasty. 2008 Dec;23(8):1122-7. Epub 2008 Apr 2
Portable Compression Device and Low-Molecular-Weight Heparin Compared With Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Joint Arthroplasty
J Arthroplasty. 2008 Dec;23(8):1122-7. Epub 2008 Apr 2